Efficacy and Safety of Photodynamic Therapy for CIN3 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Photodynamic Therapy for CIN3 — Stella

Home/Precancerous Cervical Lesion/

View on ClinicalTrials.gov

Recruiting

Back to Precancerous Cervical Lesion trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Peking Unniversity Third Hospital, Beijing

Key details

Sponsor

Peking University Third Hospital

Enrollment target

~100 participants

Started

January 2024

Primary completion

December 2028

Age range

18 Years – 65 Years

Sex

Female only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.